A multicentre, double-blind, clomipramin
β
H. Richou; P. Ruimy; J. Charbaut; J. P. Delisle; H. Brunner; M. Patris; M. Zivko
π
Article
π
1995
π
John Wiley and Sons
π
English
β 695 KB
The efficacy and tolerability of the new antidepressant Org 3770 were evaluated in a multicentre, double-blind, clomipramine-controlled trial. In total, 174 patients (126 women and 48 men), aged 18-75 years, who were suffering from a moderate or severe major depressive episode, were randomly assigne